GL1X · GenesisL1 explorer

Research workbench

Anti NEUGCGM3 ganglioside chimeric antibody CHP3

Analyse Anti NEUGCGM3 ganglioside chimeric antibody CHP3 in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
3IU4
Type
protein
Length
429 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
CHP3 Fab heavy chain; CHP3 Fab light chain
Ligands
SO4
Pockets
3 · best druggability 0.68

Structure

x-ray diffraction · 2 distinct chains · 8% helix, 51% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
HCHP3 Fab heavy chainprotein21610% helix, 52% strand—
LCHP3 Fab light chainprotein2137% helix, 50% strand—

Ligands and binding sites

  • SO4 · Sulfate ion · ion · 5 copies · chains H, L

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
17450.680.7569empty
21750.440.7433empty
3590.260.7214empty

Interfaces

1 interface between chains.

  • H–L · 1708 Ų buried · 14 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 4 disulfide, 1 modified (disulfide, cyclization).

Compared structures

  • 3IU4 · anti NeuGcGM3 ganglioside chimeric antibody chP3 · the same entry in another collection · chain H against H, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.